Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Leveraging Biomaterial Platforms to Study Aging-Related Neural and Muscular Degeneration. | Biomolecules | 2024 | 38254669 | PubTator, text mining | PubMed |
| Paediatric Neurology: Current Trends, Rehabilitation, and Future Challenges. | J Pers Med | 2024 | 38248778 | PubTator, text mining | PubMed |
| Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study. | Orphanet J Rare Dis | 2024 | 38243274 | PubTator, text mining | PubMed |
| Pure white cell aplasia before and after thymectomy in the rare conundrum of thymoma: A case report and review of the literature. | Medicine (Baltimore) | 2024 | 38241556 | PubTator, text mining | PubMed |
| Mendelian randomization analyses of known and suspected risk factors and biomarkers for myasthenia gravis overall and by subtypes. | BMC Neurol | 2024 | 38238684 | PubTator, text mining | PubMed |
| Efgartigimod is a new option for the treatment of thymoma associated myasthenia gravis: A case report. | Int J Surg Case Rep | 2024 | 38219512 | PubTator, text mining | PubMed |
| Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases. | Acta Neuropathol | 2024 | 38214778 | PubTator, text mining | PubMed |
| Unveiling the mechanistic link between extracellular amyloid fibrils, mechano-signaling and YAP activation in cancer. | Cell Death Dis | 2024 | 38199984 | PubTator, text mining | PubMed |
| Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management. | Pharmaceut Med | 2024 | 38194017 | PubTator, text mining | PubMed |
| Altered serum levels of cytokines in patients with myasthenia gravis. | Heliyon | 2024 | 38192761 | PubTator, text mining | PubMed |
| Myasthenia gravis: the changing treatment landscape in the era of molecular therapies. | Nat Rev Neurol | 2024 | 38191918 | PubTator, text mining | PubMed |
| [Clinical Features and Pathogenesis of Double Seronegative Myasthenia Gravis]. | Brain Nerve | 2024 | 38191140 | PubTator, text mining | PubMed |
| [Pathogenesis of MuSK Antibody-positive Myasthenia Gravis]. | Brain Nerve | 2024 | 38191139 | PubTator, text mining | PubMed |
| Ophthalmoplegia with a focal lesion in the interpeduncular fossa as the initial symptoms of multiple sclerosis: 3-year follow-up. | J Int Med Res | 2024 | 38190846 | PubTator, text mining | PubMed |
| Antibodies to watch in 2024. | MAbs | 2024 | 38178784 | PubTator, text mining | PubMed |
| The MuSK-BMP pathway maintains myofiber size in slow muscle through regulation of Akt-mTOR signaling. | Skelet Muscle | 2024 | 38172960 | PubTator, text mining | PubMed |
| LRP4-related signalling pathways and their regulatory role in neurological diseases. | Brain Res | 2024 | 38065285 | PubTator, text mining | PubMed |
| Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open-label extension. | Ann Clin Transl Neurol | 2024 | 38062618 | PubTator, text mining | PubMed |
| Congenital myasthenic syndrome from a MUSK gene mutation. | Pract Neurol | 2024 | 37985124 | PubTator, text mining | PubMed |
| Rituximab as a sole steroid-sparing agent in generalized myasthenia gravis: Long-term outcomes. | Neurol Sci | 2024 | 37831214 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=15